Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intralymphatic Immunotherapy Enhanced by Vitamin-D, a Randomized Placebo-controlled Trial and Comparison With SLIT

NCT06061848 is registered in ClinicalTrials.gov with Lars Olaf Cardell as lead sponsor.

NCT NCT06061848
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06061848 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intralymphatic Immunotherapy Enhanced by Vitamin-D, a Randomized Placebo-controlled Trial and Comparison With SLIT
Lead sponsor
Lars Olaf Cardell
Phase
Phase 2/3
Overall status
Recruiting
Start date
February 1, 2023
Completion date
December 28, 2031
Enrollment
360 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

allergic rhinitis due to grass pollen